Literature DB >> 20844837

Modulation of insulin sensitivity and caveolin-1 expression by orchidectomy in a nonobese type 2 diabetes animal model.

Yoon Sin Oh1, Tae Sup Lee, Gi Jeong Cheon, Ik-Soon Jang, Hee-Sook Jun, Sang Chul Park.   

Abstract

Previously, we found that male JYD mice developed type 2 diabetes but female mice did not, and that decreased expression levels of caveolin-1 were correlated with the development of a diabetic phenotype in these mice. Therefore, we hypothesized that sex hormones affect the expression of caveolin-1 and contribute to the development of insulin resistance and hyperglycemia in JYD mice. We used glucose and insulin tolerance tests to examine insulin sensitivity in male, female and orchidectomized male JYD mice. Glucose uptake was analyzed by using (18)F-fluorodeoxyglucose positron emission tomography. We also examined insulin-signaling molecules and caveolin proteins in various tissues in these mice by Western blotting. In addition, we examined changes of caveolin-1 expression in L6 skeletal muscle cells treated with 17-β estradiol or dihydroxytestosterone. We found that glucose and insulin tolerance were impaired and hyperglycemia developed in male, but not female, JYD mice. Expression of insulin-signaling molecules such as insulin receptor, protein kinase B, and glucose transporter-4 were decreased in male JYD mice compared with female mice. Orchidectomized JYD male mice showed improved glucose and insulin tolerance with a concomitant increase in the expression of insulin-signaling molecules and caveolin-1 in adipose tissue and skeletal muscle. Moreover, 17-β-estradiol treatment increased the expression of caveolin-1 in differentiated skeletal muscle cells. We conclude that sex hormones modulate the expression of caveolin-1 and insulin-signaling molecules, subsequently affecting insulin sensitivity and the development of type 2 diabetes in JYD mice.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20844837      PMCID: PMC3022979          DOI: 10.2119/molmed.2009.00105

Source DB:  PubMed          Journal:  Mol Med        ISSN: 1076-1551            Impact factor:   6.354


  40 in total

1.  A molecular dissection of caveolin-1 membrane attachment and oligomerization. Two separate regions of the caveolin-1 C-terminal domain mediate membrane binding and oligomer/oligomer interactions in vivo.

Authors:  A Schlegel; M P Lisanti
Journal:  J Biol Chem       Date:  2000-07-14       Impact factor: 5.157

Review 2.  New perspectives into the molecular pathogenesis and treatment of type 2 diabetes.

Authors:  A R Saltiel
Journal:  Cell       Date:  2001-02-23       Impact factor: 41.582

Review 3.  The estrogen trinity: membrane, cytosolic, and nuclear effects.

Authors:  A Nadal; M Díaz; M A Valverde
Journal:  News Physiol Sci       Date:  2001-12

4.  Membrane estrogen receptor engagement activates endothelial nitric oxide synthase via the PI3-kinase-Akt pathway in human endothelial cells.

Authors:  M P Haynes; D Sinha; K S Russell; M Collinge; D Fulton; M Morales-Ruiz; W C Sessa; J R Bender
Journal:  Circ Res       Date:  2000-10-13       Impact factor: 17.367

5.  Caveolin-1 interacts with androgen receptor. A positive modulator of androgen receptor mediated transactivation.

Authors:  M L Lu; M C Schneider; Y Zheng; X Zhang; J P Richie
Journal:  J Biol Chem       Date:  2001-01-18       Impact factor: 5.157

6.  Genetic analysis of a new mouse model for non-insulin-dependent diabetes.

Authors:  J H Kim; S Sen; C S Avery; E Simpson; P Chandler; P M Nishina; G A Churchill; J K Naggert
Journal:  Genomics       Date:  2001-06-15       Impact factor: 5.736

Review 7.  Diabetes in elderly adults.

Authors:  G S Meneilly; D Tessier
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2001-01       Impact factor: 6.053

8.  A potential role for skeletal muscle caveolin-1 as an insulin sensitivity modulator in ageing-dependent non-obese type 2 diabetes: studies in a new mouse model.

Authors:  Y S Oh; L-Y Khil; K A Cho; S J Ryu; M K Ha; G J Cheon; T S Lee; J-W Yoon; H-S Jun; S C Park
Journal:  Diabetologia       Date:  2008-04-12       Impact factor: 10.122

9.  Sex hormone-binding globulin and risk of type 2 diabetes in women and men.

Authors:  Eric L Ding; Yiqing Song; JoAnn E Manson; David J Hunter; Cathy C Lee; Nader Rifai; Julie E Buring; J Michael Gaziano; Simin Liu
Journal:  N Engl J Med       Date:  2009-08-05       Impact factor: 91.245

10.  Insulin signaling in the liver and uterus of ovariectomized rats treated with estradiol.

Authors:  G Koricanac; T Milosavljevic; M Stojiljkovic; Z Zakula; N Ribarac-Stepic; E R Isenovic
Journal:  J Steroid Biochem Mol Biol       Date:  2007-09-07       Impact factor: 4.292

View more
  8 in total

1.  A prevalent caveolin-1 gene variant is associated with the metabolic syndrome in Caucasians and Hispanics.

Authors:  Rene Baudrand; Mark O Goodarzi; Anand Vaidya; Patricia C Underwood; Jonathan S Williams; Xavier Jeunemaitre; Paul N Hopkins; Nancy Brown; Benjamin A Raby; Jessica Lasky-Su; Gail K Adler; Jinrui Cui; Xiuqing Guo; Kent D Taylor; Yii-Der I Chen; Anny Xiang; Leslie J Raffel; Thomas A Buchanan; Jerome I Rotter; Gordon H Williams; Luminita H Pojoga
Journal:  Metabolism       Date:  2015-09-12       Impact factor: 8.694

2.  An inquest into regulatory mechanism of caveolin by ischemic preconditioning against orchidectomy-challenged rat heart.

Authors:  Ritesh Kumar Srivastav; Tarique Mahmood Ansari; Mahesh Prasad; Vishal Kumar Vishwakarma; Prabhat Kumar Upadhyay; Farogh Ahsan; Arshiya Shamim
Journal:  Mol Cell Biochem       Date:  2021-03-01       Impact factor: 3.396

3.  Sex-dependent expression of caveolin 1 in response to sex steroid hormones is closely associated with development of obesity in rats.

Authors:  Rajib Mukherjee; Sang Woo Kim; Myung Sook Choi; Jong Won Yun
Journal:  PLoS One       Date:  2014-03-07       Impact factor: 3.240

Review 4.  Versatile Functions of Caveolin-1 in Aging-related Diseases.

Authors:  Kim Cuc Thi Nguyen; Kyung A Cho
Journal:  Chonnam Med J       Date:  2017-01-25

5.  Hepatocyte caveolin-1 modulates metabolic gene profiles and functions in non-alcoholic fatty liver disease.

Authors:  Mei Han; Weronika Piorońska; Sai Wang; Zeribe Chike Nwosu; Carsten Sticht; Shanshan Wang; Yan Gao; Matthias Philip Ebert; Steven Dooley; Christoph Meyer
Journal:  Cell Death Dis       Date:  2020-02-06       Impact factor: 8.469

6.  Caveolin-1 stabilizes ATP7A, a copper transporter for extracellular SOD, in vascular tissue to maintain endothelial function.

Authors:  Varadarajan Sudhahar; Mustafa Nazir Okur; John P O'Bryan; Richard D Minshall; David Fulton; Masuko Ushio-Fukai; Tohru Fukai
Journal:  Am J Physiol Cell Physiol       Date:  2020-09-16       Impact factor: 4.249

7.  Estradiol Binds to Insulin and Insulin Receptor Decreasing Insulin Binding in vitro.

Authors:  Robert Root-Bernstein; Abigail Podufaly; Patrick F Dillon
Journal:  Front Endocrinol (Lausanne)       Date:  2014-07-21       Impact factor: 5.555

8.  Immuno-PET imaging based radioimmunotherapy in head and neck squamous cell carcinoma model.

Authors:  In Ho Song; Youn Noh; Junhye Kwon; Jae Ho Jung; Byung Chul Lee; Kwang Il Kim; Yong Jin Lee; Joo Hyun Kang; Chae Seo Rhee; Chul Hee Lee; Tae Sup Lee; Ik Joon Choi
Journal:  Oncotarget       Date:  2017-09-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.